Table 1 Variable definitions
Variable | Operational definition |
|---|---|
CHD (yes/no) | ICD-10-GM I20-I25 |
AMI (yes/no) | ICD-10-GM I21-I23, I25.2 |
Care dependent (yes/no) | Formal care grade present, as evaluated |
DMP participation/utilisation (yes/no) | Registration in any DMP |
Continuous primary care (yes/no) | At least one consultation either with a general practitioner or a cardiologist per year in the years 2018, 2019, and 2020 |
Cardiologist treatment: continuous utilisation | Cardiologist consultation every year in 2018, 2019, and 2020 |
Cardiologist treatment: sporadic utilisation | At least one cardiologist consultation in 2018, 2019 or 2020, but not in every year |
Cardiologist treatment: no utilisation | No cardiologist consultation in 2018, 2019 or 2020 |
QiSA indicator 6 beta-blocker prescription with heart failure (eligible yes/no) | Stable CHD (ICD-10-GM I25) and heart failure (ICD-10-GM I50), excluding pulmonary heart disease (ICD-10-GM I27) or asthma (ICD-10-GM J45) |
QiSA indicator 6 beta-blocker prescription with heart failure (prescribed yes/no) | Relevant drugs: ATC-codes C07 |
QiSA indicator 7 beta-blocker prescription after acute myocardial infarction (eligible yes/no) | Stable CHD (ICD-10-GM I25) and acute myocardial infarction (ICD-10-GM I21-I23, I25.2, hospital diagnosis), excluding myocardial infarction that occurred more than two years ago, or diagnosed with asthma (ICD-10-GM J45) |
QiSA indicator 7 beta-blocker prescription after acute myocardial infarction (prescribed yes/no) | Relevant drugs: ATC-codes C07 |
QiSA indicator 8 statin prescription (eligible yes/no) | Eligible patients with CHD (ICD-10-GM I20-I25), excluding patients > 73 years and a diagnosed ischemicischemic cardiomyopathy (ICD-10-GM I25.5), and patients with diabetes type II (ICD-10-GM E11) and terminal renal insufficiency (ICD-10-GM N18.5) |
QiSA indicator 8 statin prescription (prescribed yes/no) | Relevant drugs: ATC-codes C10AA, C10BA and/or C10BX |
QiSA indicator 9 ACE inhibitors or AT-II antagonists prescription with heart failure and/or high blood pressure (eligible yes/no) | Eligible patients with stable CHD (ICD-10-GM I25), and heart failure (ICD-10-GM I50) and/or high blood pressure (ICD-10-GM I10-I15), excluding patients with pulmonary heart disease (I27) |
QiSA indicator 9 ACE inhibitors or AT-II antagonists prescription with heart failure and/or high blood pressure (prescribed yes/no) | Relevant drugs: ATC-codes C09A, C09B,C09C and/or C09D |